Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease

Published:2011-01 Issue:1 Volume:9 Page:30-35
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Cottone Mario,Kohn Anna,Daperno Marco,Armuzzi Alessandro,Guidi Luisa,D'Inca Renata,Bossa Fabrizio,Angelucci Erika,Biancone Livia,Gionchetti Paolo,Ardizzone Sandro,Papi Claudio,Fries Walter,Danese Silvio,Riegler Gabriele,Cappello Maria,Castiglione Fabiana,Annese Vito,Orlando Ambrogio

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference23 articles.

1. Consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21–23, 2006;Gastroenterology,2007

2. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management;Dignass;J Crohn's Colitis,2010

3. European evidence-based consensus on the management of ulcerative colitis: current management;Travis;J Crohn's Colitis,2008

4. Treatment of inflammatory bowel disease in the elderly: an update;Pardi;Drugs Aging,2002

5. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease;Lichtenstein;Gastroenterology,2005

Cited by 317 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical Management of Inflammatory Bowel Disease in the Elderly;Canadian IBD Today;2024-09-11

2. A Study of Patient Concerns in the Modern Therapeutic Era of Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2024-08-27

3. Common Mistakes in Managing Patients with Inflammatory Bowel Disease;Journal of Clinical Medicine;2024-08-14

4. Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn’s Disease Patients;Inflammatory Bowel Diseases;2024-08-03

5. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08